No Data
No Data
Express News | Eli Lilly and Co's treatment drug has been granted orphan drug status by the FDA.
Eli Lilly and Co (LLY.US) sues three American entities for "counterfeiting" their own brand of weight loss drugs.
eli lilly and co announced on Monday that it has sued three medical spas and online retailers, claiming that their products contain terlipressin.
Barclays Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,025
Buy ahead of time in 2016? Benefiting from the 'Trump trade,' assets are outpacing the market, but this time 'it's somewhat different.'
Republican presidential candidate Trump's polls are reversing, and the 'winning odds' are gradually increasing. A Merrill Lynch strategist pointed out that investors seem to be rushing to allocate to symbols that performed well after Trump's victory in 2016. What inspiration does this have for investment?
Express News | Lilly Sues Mangorx, Pivotal Peptides, Genesis Lifestyle Medicine of Nevada for Selling Versions of Tirzepatide - Court Filings
Eli Lilly (LLY): Revenue Boost From Zepbound and Mounjaro Amid Strong Market Projections